Poly(ethylene glycol) shell-sheddable magnetic nanomicelle as the carrier of doxorubicin with enhanced cellular uptake

Colloids and Surfaces B: Biointerfaces

Volumn 107, Issue , 2013, Pages 213-219

  Yu, Jiahui ^a   Li, Xiangyang ^a   Luo, Yu ^a   Lu, Wei ^a   Huang, Jin ^a,b   Liu, Shiyuan ^c  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b WUHAN UNIVERSITY OF TECHNOLOGY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Doxorubicin; Enhanced cellular uptake ability; MRI visible drug carrier; Poly (l succinimide); Shell sheddable magnetic nanomicelle

Indexed keywords

CELLULAR UPTAKE; DOXORUBICIN; DRUG CARRIER; NANOMICELLE; POLY (L-SUCCINIMIDE);

CELL CULTURE; DYNAMIC LIGHT SCATTERING; GRAFT COPOLYMERS; GRAFTING (CHEMICAL); MAGNETIC RESONANCE IMAGING; MOTION PICTURE EXPERTS GROUP STANDARDS; POLYETHYLENE GLYCOLS; SHELLS (STRUCTURES);

NANOMAGNETICS;

COPOLYMER; DITHIOTHREITOL; DOXORUBICIN; MACROGOL; MAGNETITE; NANOCARRIER; NANOPARTICLE; POLY(ETHYLENE GLYCOL)MONOMETHYL ETHER GRAFT PASP DOPAMINE MAGNETITE NANOMICELLE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DEGRADATION KINETICS; DISULFIDE BOND; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT SCATTERING; MICELLIZATION; MOLECULAR IMAGING; NANOANALYSIS; NANOFABRICATION; NANOPHARMACEUTICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS DEVELOPMENT;

CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DOPAMINE; DOXORUBICIN; DRUG CARRIERS; ENDOCYTOSIS; FERUMOXYTOL; HUMANS; MAGNETIC PHENOMENA; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MICROSCOPY, CONFOCAL; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

EID: 84875281106     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.02.009     Document Type: Article

References (25)

1. Leconte Y., Veintemillas-Verdaguer S., Morales M.P., et al. J. Colloid Interface Sci. 2007, 313:511.
2. Leslie-Pelecky D.L., Rieke R.D. Chem. Mater. 1996, 8:1770.
3. Cui Z., Mumper R.J. Crit. Rev. Ther. Drug Carrier Syst. 2003, 20:103.
4. Kaul G., Amiji M. Pharm. Res. 2002, 19:1061.
5. Leong K.W., Mao H.Q., Truong-Le V.L., et al. J. Control. Release 1998, 53:183.
6. Li Y., Ogris M., Wagner E., et al. Int. J. Pharm. 2003, 259:93.
7. Mao H.Q., Roy K., Troung-Le V.L., et al. J. Control. Release 2001, 70:399.
8. Moghimi S.M., Hunter A.C., Murray J.C. Pharma. Rev. 2001, 53:283.
9. Roy K., Mao H.Q., Huang S.K., et al. Nat. Med. 1999, 5:387.
10. Otsuka H., Nagasaki Y., Kataoka K. Adv. Drug Deliv. Rev. 2003, 5:403.
11. Vonarbourg A., Passirani C., Saulnier P., et al. Biomaterials 2006, 27:4356.
12. Takae S., Miyata K., Oba M., et al. J. Am. Chem. Soc. 2008, 130:6001.
13. Yoo H.S., Park T.G. J. Control. Release 2004, 96:273.
14. Nasongkla N., Bey E., Ren J., et al. Nano Lett. 2006, 6:2427.
15. Guthi J.S., Yang S.G., Huang G., et al. Mol. Pharm. 2009, 7:32.
16. Chen G.H., Chen W.J., Wu Z., et al. Biomaterials 2009, 30:1962.
17. Sun Q.Q., Cheng D., Yu X.S., et al. J. Mater. Chem. 2011, 21:15316.
18. Xue Y.K., Tang X.X., Huang J., et al. Colloids Surf. B 2011, 85:280.
19. Kuppusamy P., Afeworki M., Shankar R.A., et al. Cancer Res. 1998, 58:1562.
20. Kuppusamy P., Li H., Ilangovan G., et al. Cancer Res. 2002, 62:307.
21. Sun S.H., Zeng H. J. Am. Chem. Soc. 2002, 124:8204.
22. Zhao Y., Su H.J., Fang L., et al. Polymer 2005, 46:5368.
23. Sun H.L., Guo B.N., Cheng R., et al. Biomaterials 2009, 30:6358.
24. Zhang X.Z., Du F., Huang J., et al. Colloids Surf. B 2012, 100:155.
25. Opanasopit P., Yokoyama M., Watanabe M., et al. J. Control. Release 2005, 104:313.